These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. Halene TB; Siegel SJ J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599 [TBL] [Abstract][Full Text] [Related]
25. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B. Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317 [TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. Gantner F; Tenor H; Gekeler V; Schudt C; Wendel A; Hatzelmann A J Allergy Clin Immunol; 1997 Oct; 100(4):527-35. PubMed ID: 9338548 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956 [TBL] [Abstract][Full Text] [Related]
28. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs. Spina D; Landells LJ; Page CP Clin Exp Allergy; 1998 Aug; 28 Suppl 3():24-34. PubMed ID: 9756183 [TBL] [Abstract][Full Text] [Related]
29. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration. Danahay H; Broadley KJ Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122 [TBL] [Abstract][Full Text] [Related]
30. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479 [TBL] [Abstract][Full Text] [Related]
31. CDP840: a novel inhibitor of PDE-4. Perry MJ; O'Connell J; Walker C; Crabbe T; Baldock D; Russell A; Lumb S; Huang Z; Howat D; Allen R; Merriman M; Walls J; Daniel T; Hughes B; Laliberte F; Higgs GA; Owens RJ Cell Biochem Biophys; 1998; 29(1-2):113-32. PubMed ID: 9631241 [TBL] [Abstract][Full Text] [Related]
32. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia. Kim DH; Lerner A Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789 [TBL] [Abstract][Full Text] [Related]
33. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295 [TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
35. Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats. Sato T; Otaka M; Odashima M; Kato S; Jin M; Konishi N; Matsuhashi T; Watanabe S Biochem Biophys Res Commun; 2006 Jul; 346(1):339-44. PubMed ID: 16759642 [TBL] [Abstract][Full Text] [Related]
36. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Zhou L; Thompson WJ; Potter DE Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044 [TBL] [Abstract][Full Text] [Related]
37. Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Banner KH; Roberts NM; Page CP Br J Pharmacol; 1995 Dec; 116(8):3169-74. PubMed ID: 8719792 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism. Shechter Y Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014 [TBL] [Abstract][Full Text] [Related]